Fingerprint
Dive into the research topics where Ellen M. Westerhout is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Synergistic inhibition of CHK1 and MUS81 to combat replication stress resistance in high-risk neuroblastoma
Hilgert, E., van Neste, C., Bekaert, S.-L., Martens, F., Vanhauwaert, S., Sanders, E., Verstraelen, P., Risseeuw, M., Westerhout, E. M., Grannetia, M. A., van Calenbergh, S., van Roy, N., de Vos, W. H., Wolthuis, R. W. F., Speleman, F., Depestel, L. & Durinck, K., 1 Dec 2025, In: Scientific reports. 15, 1, 45546.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile13 Downloads (Pure) -
FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity
Santo, E. E., Ribel-Madsen, R., Stroeken, P. J., de Boer, V. C. J., Hansen, N. S., Commandeur, M., Vaag, A. A., Versteeg, R., Paik, J. & Westerhout, E. M., Mar 2023, In: Aging cell. 22, 3, e13763.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile33 Downloads (Pure) -
COMBINATION THERAPY OF ALK-POSITIVE NEOPLASIA
Versteeg, R. (Inventor), Hamdi, M. (Inventor) & Westerhout, E. M. (Inventor), 28 Apr 2022, IPC No. A61K31/439 A61K31/5377 A61P35/00, Patent No. US2022125770A1, 1 Oct 2020, Priority date 27 Mar 2019Research output: Patent › Academic
-
DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
Olsen, T. K., Dyberg, C., Embaie, B. T., Alchahin, A., Milosevic, J., Ding, J., Otte, J. R., Tümmler, C., Myrberg, I. H., Westerhout, E. M., Koster, J., Versteeg, R., Ding, H.-F., Kogner, P., Johnsen, J. I., Sykes, D. B. & Baryawno, N., 8 Sept 2022, In: JCI insight. 7, 17Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile33 Downloads (Pure) -
Erratum: Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors (Cancer Res (2022) 82 (484–496) DOI: 10.1158/0008-5472.CAN-21-1621)
Westerhout, E. M., Hamdi, M., Stroeken, P., Nowakowska, N. E., Lakeman, A., van Arkel, J., Hasselt, N. E., Blejlevens, B., Akogul, N., Haneveld, F., Chan, A., van Sluis, P., Zwijnenburg, D., Volckmann, R., van Noesel, C. J. M., Adameyko, I., van Gronigen, T., Koster, J., Valentijn, L. J. & van Nes, J. & 1 others, , 15 Jul 2022, In: Cancer research. 82, 14, p. 2657 1 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access